高级检索
当前位置: 首页 > 详情页

Dietary sugar consumption and health: umbrella review

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. [2]Department of Oncology, West China Hospital, Sichuan University, Chengdu, China. [3]Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China. [4]Department of Clinical Nutrition, West China Hospital, Sichuan University, Chengdu, China. [5]Research Core Facility, West China Hospital, Sichuan University, Chengdu, China. [6]Department of Urologic Surgery, UC Davis School of Medicine, Sacramento, CA, USA
出处:
ISSN:

摘要:
To evaluate the quality of evidence, potential biases, and validity of all available studies on dietary sugar consumption and health outcomes.Umbrella review of existing meta-analyses.PubMed, Embase, Web of Science, Cochrane Database of Systematic Reviews, and hand searching of reference lists.Systematic reviews and meta-analyses of randomised controlled trials, cohort studies, case-control studies, or cross sectional studies that evaluated the effect of dietary sugar consumption on any health outcomes in humans free from acute or chronic diseases.The search identified 73 meta-analyses and 83 health outcomes from 8601 unique articles, including 74 unique outcomes in meta-analyses of observational studies and nine unique outcomes in meta-analyses of randomised controlled trials. Significant harmful associations between dietary sugar consumption and 18 endocrine/metabolic outcomes, 10 cardiovascular outcomes, seven cancer outcomes, and 10 other outcomes (neuropsychiatric, dental, hepatic, osteal, and allergic) were detected. Moderate quality evidence suggested that the highest versus lowest dietary sugar consumption was associated with increased body weight (sugar sweetened beverages) (class IV evidence) and ectopic fatty accumulation (added sugars) (class IV evidence). Low quality evidence indicated that each serving/week increment of sugar sweetened beverage consumption was associated with a 4% higher risk of gout (class III evidence) and each 250 mL/day increment of sugar sweetened beverage consumption was associated with a 17% and 4% higher risk of coronary heart disease (class II evidence) and all cause mortality (class III evidence), respectively. In addition, low quality evidence suggested that every 25 g/day increment of fructose consumption was associated with a 22% higher risk of pancreatic cancer (class III evidence).High dietary sugar consumption is generally more harmful than beneficial for health, especially in cardiometabolic disease. Reducing the consumption of free sugars or added sugars to below 25 g/day (approximately 6 teaspoons/day) and limiting the consumption of sugar sweetened beverages to less than one serving/week (approximately 200-355 mL/week) are recommended to reduce the adverse effect of sugars on health.PROSPERO CRD42022300982.© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.

基金:
语种:
PubmedID:
第一作者:
第一作者机构: [1]Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43389 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号